Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.

PloS one - 1 Jan 2018

Lunar Maja M, Židovec Lepej Snježana, Tomažič Janez, Vovko Tomaž D, Pečavar Blaž, Turel Gabriele, Maver Manja, Poljak Mario

Abstract excerpt

HIV-positive individuals that have a detected transmitted drug resistance (TDR) at baseline have a higher risk of virological failure with antiretroviral therapy (ART). This study offers an update on the prevalence of TDR in Slovenia, looks for onward transmission of TDR, and reassesses the need for baseline drug resistance testing. Blinded questionnaires and partial pol sequences were obtained from 54.5%...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Homosexuality, Male

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Share to Slovenia

Source

Open in PubMed Open full text

Identifiers

PMID: 29698470
DOI: 10.1371/journal.pone.0196670
PMCID: PMC5919638

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.PMID 29698470Read ↗

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.Semantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Slovakia: update 2017-2018.Semantic proximity Read ↗

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.Semantic proximity Read ↗

HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

[Prevalence of transmitted drug resistance in HIV-infected treatment-naive patients in Chile].Semantic proximity Read ↗

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study CohortSemantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

Prevalence of Transmitted HIV-1 Drug Resistance Among Treatment-naive Individuals in China, 2000-2016Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.